Larry Andrew Alegria

Title: Innovations of Larry Andrew Alegria

Introduction

Larry Andrew Alegria is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cell proliferation. With a total of 2 patents, his work has implications for treating various diseases, including cancer.

Latest Patents

Alegria's latest patents include innovative compounds such as thiazole benzamide derivatives and pharmaceutical compositions designed to inhibit cell proliferation. These thiazole compounds are specifically aimed at inhibiting protein kinases, which play a crucial role in cell signaling. The therapeutic applications of these compounds extend to treating conditions associated with unwanted angiogenesis and cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis.

Career Highlights

Larry Alegria is currently associated with Agouron Pharmaceuticals, Inc., where he continues to advance his research in pharmaceutical innovations. His work focuses on developing effective treatments that can significantly improve patient outcomes in various medical conditions.

Collaborations

Throughout his career, Alegria has collaborated with esteemed colleagues, including Shao Song Chu and Steven Lee Bender. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Larry Andrew Alegria's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to advancing medical science. His work not only addresses critical health issues but also paves the way for future research in the treatment of complex diseases.